Search Results - "Maclauchlin, Chris"
-
1
Endosomal escape for intracellular delivery of RNA therapeutics: current and future strategies
Published in Drug metabolism and pharmacokinetics (01-04-2024)Get full text
Journal Article -
2
Analyzing the Mechanisms Behind Macrolide Antibiotic-Induced Liver Injury Using Quantitative Systems Toxicology Modeling
Published in Pharmaceutical research (01-03-2019)“…Purpose Macrolide antibiotics are commonly prescribed treatments for drug-resistant bacterial infections; however, many macrolides have been shown to cause…”
Get full text
Journal Article -
3
The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of N -Acetylgalactosamine-Conjugated Small Interfering RNA Are Highly Predictable and Build Confidence in Translation to Human
Published in Drug metabolism and disposition (01-06-2022)“…Conjugation of oligonucleotide therapeutics, including small interfering RNAs (siRNAs) or antisense oligonucleotides, to -acetylgalactosamine (GalNAc) ligands…”
Get full text
Journal Article -
4
A Randomized Study Evaluating Oral Fusidic Acid (CEM-102) in Combination With Oral Rifampin Compared With Standard-of-Care Antibiotics for Treatment of Prosthetic Joint Infections: A Newly Identified Drug-Drug Interaction
Published in Clinical infectious diseases (15-12-2016)“…Background. Fusidic acid (FA) has been used for decades for bone infection, including prosthetic joint infection (PJI), often in combination with rifampin…”
Get full text
Journal Article -
5
Biotransformation research advances - 2022 year in review
Published in Drug metabolism reviews (01-11-2023)“…This annual review is the eighth of its kind since 2016 (Baillie et al. 2016, Khojasteh et al. 2017, Khojasteh et al. 2018, Khojasteh et al. 2019, Khojasteh…”
Get full text
Journal Article -
6
Leveraging microphysiological systems to address challenges encountered during development of oligonucleotide therapeutics
Published in ALTEX, alternatives to animal experimentation (2022)“…Oligonucleotide therapeutics (ONTs) encompass classes of medicines that selectively target and potentially ameliorate previously untreatable and often rare…”
Get full text
Journal Article